Dr. Cirstea is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114
Education & Training
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Mount Auburn HospitalResidency, Internal Medicine, 2013 - 2016
Nicolae Testemitanu State University of Medicine and PharmacyClass of 2000
Certifications & Licensure
MA State Medical License 2013 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsIsatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 t...Elizabeth O'Donnell, Clifton Mo, Andrew J Yee, Omar Nadeem, Jacob Laubach
The Lancet. Haematology. 2024-06-01 - 8 citationsLack of differential impact of del17p on survival in African Americans compared with White patients with multiple myeloma: a VA studyNathanael Fillmore, Diana Cirstea, Anusha Munjuluri, Hassan Yameen, Sarvari Venkata Yellapragada
Blood Advances. 2021-09-28 - 11 citationsDefining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma.Nathanael Fillmore, Clark DuMontier, Cenk Yildirim, Jennifer La, Mara M. Epstein
Journal of the National Cancer Institute. 2021-08-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
